SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-21-000135
Filing Date
2021-06-28
Accepted
2021-06-28 07:30:35
Documents
12
Period of Report
2021-06-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20210628.htm   iXBRL 8-K 45921
  Complete submission text file 0001651308-21-000135.txt   190170

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20210628.xsd EX-101.SCH 1996
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20210628_lab.xml EX-101.LAB 25214
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20210628_pre.xml EX-101.PRE 13249
5 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20210628_htm.xml XML 11485
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 211049960
SIC: 2834 Pharmaceutical Preparations